Silence Therapeutics plc (SLNCF) Capital expenditures 2022–2025
Silence Therapeutics plc (SLNCF) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$55,000FY2025 · since FY2022: $173,000 → $55,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $55,000 | -73.9% |
| FY2024 | $211,000 | +276.8% |
| FY2023 | $56,000 | -67.6% |
| FY2022 | $173,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice
More SLNCF financial trends
SLNCF RevenueSLNCF Net incomeSLNCF Net marginSLNCF Gross profitSLNCF Gross marginSLNCF Operating incomeSLNCF Operating marginSLNCF Operating cash flowSLNCF Free cash flowSLNCF Return on equitySLNCF Stock buybacksSLNCF Dividends paidSLNCF Total assetsSLNCF Total liabilitiesSLNCF Shareholders’ equitySLNCF overview →